p38/p53/miR-200a-3p feedback loop promotes oxidative stress-mediated liver cell death

Cell Cycle

Volumn 14, Issue 10, 2015, Pages 1548-1558

  Xiao, Yongtao ^a,b,c   Yan, Weihui ^a,c   Lu, Lina ^a,c   Wang, Ying ^a,c   Lu, Wei ^a,c   Cao, Yi ^a,c   Cai, Wei ^a,b,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Institute of Pediatric Research   (China)

^c Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition   (China)

Author keywords

Liver injury; MicroRNA; Oxidative stress; P38; P53

Indexed keywords

GLUTATHIONE; HYDROGEN PEROXIDE; MICRORNA; MICRORNA 141 3P; MICRORNA 200A 3P; MICRORNA 200B 3P; MICRORNA 200C 3P; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P53; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; ANTISENSE OLIGONUCLEOTIDE; MIRN200 MICRORNA, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 14; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EXPERIMENTAL LIVER INJURY; HUMAN; HUMAN CELL; LIVER CELL; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TOTAL PARENTERAL NUTRITION; UPREGULATION; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL LINE; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; PHOSPHORYLATION; RNA INTERFERENCE;

APOPTOSIS; CELL LINE; EPITHELIAL-MESENCHYMAL TRANSITION; HEPATOCYTES; HUMANS; HYDROGEN PEROXIDE; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE 14; OLIGONUCLEOTIDES, ANTISENSE; OXIDATIVE STRESS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84943775812     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.1080/15384101.2015.1026491     Document Type: Article

References (46)

1. Burrin DG, Stoll B, Jiang R, Chang X, Hartmann B, Holst JJ, Greeley GH Jr, Reeds PJ. Minimal enteral nutrient requirements for intestinal growth in neonatal piglets: how much is enough? Am J Clin Nutr 2000; 71: 1603-10; PMID: 10837305.
2. Baserga MC, Sola A. Intrauterine growth restriction impacts tolerance to total parenteral nutrition in extremely low birth weight infants. J Perinat: Off J Calif Perinat Assoc 2004; 24: 476-81; PMID: 15141267; http://dx. doi. org/10. 1038/sj. jp. 7211137.
3. Lavoie JC, Chessex P. Gender and maturation affect glutathione status in human neonatal tissues. Free Radical Biol Med 1997; 23: 648-57; PMID: 9215810; http://dx. doi. org/10. 1016/S0891-5849(97)00011-7.
4. Lavoie JC, Belanger S, Spalinger M, Chessex P. Admixture of a multivitamin preparation to parenteral nutrition: the major contributor to in vitro generation of peroxides. Pediatrics 1997; 99: E6; PMID: 9099771; http://dx. doi. org/10. 1542/peds. 99. 3. e6.
5. Neuzil J, Darlow BA, Inder TE, Sluis KB, Winterbourn CC, Stocker R. Oxidation of parenteral lipid emulsion by ambient and phototherapy lights: potential toxicity of routine parenteral feeding. J Pediat 1995; 126: 785-90; PMID: 7752007; http://dx. doi. org/10. 1016/S0022-3476(95)70412-4.
6. Laborie S, Lavoie JC, Chessex P. Increased urinary peroxides in newborn infants receiving parenteral nutrition exposed to light. J Pediat 2000; 136: 628-32; PMID: 10802495; http://dx. doi. org/10. 1067/mpd. 2000. 105131.
7. Laborie S, Lavoie JC, Pineault M, Chessex P. Contribution of multivitamins, air, and light in the generation of peroxides in adult and neonatal parenteral nutrition solutions. Ann Pharmacother 2000; 34: 440-5; PMID: 10772427; http://dx. doi. org/10. 1345/aph. 19182.
8. Hong L, Wang X, Wu J, Cai W. Mitochondria-initiated apoptosis triggered by oxidative injury play a role in total parenteral nutrition-associated liver dysfunction in infant rabbit model. J Pediat Surg 2009; 44: 1712-8; PMID: 19735813; http://dx. doi. org/10. 1016/j. jpedsurg. 2009. 04. 002.
9. CaiW, Wu J, Hong L, Xu Y, Tang Q, Shi C. Oxidative injury and hepatocyte apoptosis in total parenteral nutrition-associated liver dysfunction. J Pediat Surg 2006; 41: 1663-8; PMID: 17011265; http://dx. doi. org/10. 1016/j. jpedsurg. 2006. 05. 067.
10. Elremaly W, Rouleau T, Lavoie JC. Inhibition of hepatic methionine adenosyltransferase by peroxides contaminating parenteral nutrition leads to a lower level of glutathione in newborn Guinea pigs. Free Radical Biol Med 2012; 53: 2250-5; PMID: 23085223; http://dx. doi. org/10. 1016/j. freeradbiomed. 2012. 10. 541.
11. Miloudi K, Tsopmo A, Friel JK, Rouleau T, Comte B, Lavoie JC. Hexapeptides from human milk prevent the induction of oxidative stress from parenteral nutrition in the newborn guinea pig. Pediat Res 2012; 71: 675-81; PMID: 22337230; http://dx. doi. org/10. 1038/pr. 2012. 29.
12. Jaeschke H, Bajt ML. Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol Sci: Off J Soc Toxicol 2006; 89: 31-41; PMID: 16177235; http://dx. doi. org/10. 1093/toxsci/kfi336.
13. Bilzer M, Jaeschke H, Vollmar AM, Paumgartner G, Gerbes AL. Prevention of Kupffer cell-induced oxidant injury in rat liver by atrial natriuretic peptide. Am J Physiol 1999; 276: G1137-44; PMID: 10330004.
14. Ashwell JD. The many paths to p38 mitogen-activated protein kinase activation in the immune system. Nat Rev Immunol 2006; 6: 532-40; PMID: 16799472; http://dx. doi. org/10. 1038/nri1865.
15. Coulthard LR, White DE, Jones DL, McDermott MF, Burchill SA. p38(MAPK): stress responses from molecular mechanisms to therapeutics. Trends Mol Med 2009; 15: 369-79; PMID: 19665431; http://dx. doi. org/10. 1016/j. molmed. 2009. 06. 005.
16. Wang B, Li D, Kovalchuk O. p53 Ser15 phosphorylation and histone modifications contribute to IRinduced miR-34a transcription in mammary epithelial cells. Cell Cycle 2013; 12: 2073-83; PMID: 23759592; http://dx. doi. org/10. 4161/cc. 25135.
17. Mateescu B, Batista L, Cardon M, Gruosso T, de Feraudy Y, Mariani O, Nicolas A, Meyniel JP, Cottu P, Sastre-Garau X, et al. miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med 2011; 17: 1627-35; PMID: 22101765; http://dx. doi. org/10. 1038/nm. 2512.
18. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007; 26: 731-43; PMID: 17540598; http://dx. doi. org/10. 1016/j. molcel. 2007. 05. 017.
19. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-33; PMID: 19167326; http://dx. doi. org/10. 1016/j. cell. 2009. 01. 002.
20. Marsit CJ, Eddy K, Kelsey KT. MicroRNA responses to cellular stress. Cancer Res 2006; 66: 10843-8; PMID: 17108120; http://dx. doi. org/10. 1158/0008-5472. CAN-06-1894.
21. Wang Z, Liu Y, Han N, Chen X, Yu W, Zhang W, Zou F. Profiles of oxidative stress-related microRNA and mRNA expression in auditory cells. Brain Res 2010; 1346: 14-25; PMID: 20510889; http://dx. doi. org/10. 1016/j. brainres. 2010. 05. 059.
22. Magenta A, Cencioni C, Fasanaro P, Zaccagnini G, Greco S, Sarra-Ferraris G, Antonini A, Martelli F, Capogrossi MC. miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death Differ 2011; 18: 1628-39; PMID: 21527937; http://dx. doi. org/10. 1038/cdd. 2011. 42.
23. Tormos AM, Arduini A, Talens-Visconti R, del Barco Barrantes I, Nebreda AR, Sastre J. Liver-specific p38alpha deficiency causes reduced cell growth and cytokinesis failure during chronic biliary cirrhosis in mice. Hepatology 2013; 57: 1950-61; PMID: 23354775; http://dx. doi. org/10. 1002/hep. 26174.
24. Tormos AM, Talens-Visconti R, Nebreda AR, Sastre J. p38 MAPK: a dual role in hepatocyte proliferation through reactive oxygen species. Free Radical Res 2013; 47: 905-16; PMID: 23906070; http://dx. doi. org/10. 3109/10715762. 2013. 821200.
25. Niture SK, Kaspar JW, Shen J, Jaiswal AK. Nrf2 signaling and cell survival. Toxicol Appl Pharmacol 2010; 244: 37-42; PMID: 19538984; http://dx. doi. org/10. 1016/j. taap. 2009. 06. 009.
26. Hybertson BM, Gao B, Bose SK, McCord JM. Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Mol Aspects Med 2011; 32: 234-46; PMID: 22020111; http://dx. doi. org/10. 1016/j. mam. 2011. 10. 006.
27. Knouf EC, Garg K, Arroyo JD, Correa Y, Sarkar D, Parkin RK, Wurz K, O'Briant KC, Godwin AK, Urban ND, et al. An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription. Nucleic Acids Res 2012; 40: 499-510; PMID: 21917857; http://dx. doi. org/10. 1093/nar/gkr731.
28. Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S, Pineau P, Marchio A, Palatini J, Suh SS, et al. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med 2011; 208: 875-83; PMID: 21518799; http://dx. doi. org/10. 1084/jem. 20110235.
29. Rotblat B, Grunewald TG, Leprivier G, Melino G, Knight RA. Anti-oxidative stress response genes: bioinformatic analysis of their expression and relevance in multiple cancers. Oncotarget 2013; 4: 2577-90; PMID: 24342878.
30. Jones B. Neurodegenerative disease: Oxidative stress in cells near amyloid plaques linked to neuronal death. Nat Rev Neurol 2013; 9: 300; PMID: 23689186; http://dx. doi. org/10. 1038/nrneurol. 2013. 87.
31. Raninga PV, Trapani GD, Tonissen KF. Cross Talk between Two Antioxidant Systems, Thioredoxin and DJ-1: Consequences for Cancer. Oncoscience 2014; 1: 95-110; PMID: 25593990.
32. Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, Zhang Q, Wong CH, Wang H, Ungewiss C, Ahn YH, et al. Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. Cancer Res 2011; 71: 7670-82; PMID: 21987723; http://dx. doi. org/10. 1158/0008-5472. CAN-11-0964.
33. Korpal M, Lee ES, Hu G, Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 2008; 283: 14910-4; PMID: 18411277; http://dx. doi. org/10. 1074/jbc. C800074200.
34. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593-601; PMID: 18376396; http://dx. doi. org/10. 1038/ncb1722.
35. Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 2009; 9: 537-49; PMID: 19629069; http://dx. doi. org/10. 1038/nrc2694.
36. Dolado I, Swat A, Ajenjo N, De Vita G, Cuadrado A, Nebreda AR. p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell 2007; 11: 191-205; PMID: 17292829; http://dx. doi. org/10. 1016/j. ccr. 2006. 12. 013.
37. Awad MM, Enslen H, Boylan JM, Davis RJ, Gruppuso PA. Growth regulation via p38 mitogen-activated protein kinase in developing liver. J Biol Chem 2000; 275: 38716-21; PMID: 10995779; http://dx. doi. org/10. 1074/jbc. M008040200.
38. Ventura JJ, Tenbaum S, Perdiguero E, Huth M, Guerra C, Barbacid M, Pasparakis M, Nebreda AR. p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat Gen 2007; 39: 750-8; PMID: 17468755; http://dx. doi. org/10. 1038/ng2037.
39. Eades G, Yang M, Yao Y, Zhang Y, Zhou Q. miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells. J Biol Chem 2011; 286: 40725-33; PMID: 21926171; http://dx. doi. org/10. 1074/jbc. M111. 275495.
40. Kim NH, Kim HS, Li XY, Lee I, Choi HS, Kang SE, Cha SY, Ryu JK, Yoon D, Fearon ER, et al. A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J Cell Biol 2011; 195: 417-33; PMID: 22024162; http://dx. doi. org/10. 1083/jcb. 201103097.
41. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007; 26: 745-52; PMID: 17540599; http://dx. doi. org/10. 1016/j. molcel. 2007. 05. 010.
42. Boominathan L. The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. PloS One 2010; 5: e10615; PMID: 20485546; http://dx. doi. org/10. 1371/journal. pone. 0010615.
43. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. Modulation of microRNA processing by p53. Nature 2009; 460: 529-33; PMID: 19626115; http://dx. doi. org/10. 1038/nature08199.
44. Hermeking H. p53 enters the microRNA world. Cancer Cell 2007; 12: 414-8; PMID: 17996645; http://dx. doi. org/10. 1016/j. ccr. 2007. 10. 028.
45. Chang CJ, Chao CH, Xia W, Yang JY, Xiong Y, Li CW, Yu WH, Rehman SK, Hsu JL, Lee HH, et al. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 2011; 13: 317-23; PMID: 21336307; http://dx. doi. org/10. 1038/ncb2173.
46. Sanjana NE, Cong L, Zhou Y, Cunniff MM, Feng G, Zhang F. A transcription activator-like effector toolbox for genome engineering. Nat Protoc 2012; 7: 171-92; PMID: 22222791; http://dx. doi. org/10. 1038/nprot. 2011. 431.